Post-Traumatic Stress Disorder

Detailed Overview

While most people experience stress reactions following trauma, PTSD is diagnosed when these symptoms persist beyond one month and cause significant functional impairment. The trauma can be a single event (e.g., car accident, assault, natural disaster) or complex, prolonged exposure (e.g., childhood abuse, combat). The condition fundamentally alters the brain's fear-processing network, causing the individual to perceive current safety through the lens of past trauma. Patients frequently suffer from severe sleep disturbances, dissociation, and crippling survivor's guilt, heavily impacting their interpersonal relationships and ability to work.

Epidemiology & Demographics

Lifetime prevalence in the US is approximately 6-8%. Women are twice as likely as men to develop PTSD, largely due to higher rates of exposure to sexual assault and interpersonal violence. Prevalence among combat veterans is heavily elevated (up to 15-30%).

Etiological Mechanism

Requires a precipitating traumatic event (Criterion A: exposure to actual or threatened death, serious injury, or sexual violence). However, exposure alone is not sufficient; genetic, neurobiological, and psychosocial vulnerabilities interact to prevent the normal extinction of the fear memory.

Primary Causes

Triggered by trauma. The failure of the brain to properly consolidate and extinguish the memory of the traumatic event, leading to the memory being stored as a present, ongoing threat rather than a past narrative.

• Trauma Severity: Dose-response relationship; greater intensity, duration, and proximity to the trauma increase risk.
• Interpersonal Trauma: Trauma inflicted by other humans (rape, torture) carries a much higher risk than natural disasters.
• Lack of Support: Poor social support immediately following the trauma hinders natural recovery.
• Prior Psychiatric History: Pre-existing depression or anxiety disorders increase vulnerability.

PTSD is characterized by a hyperactive amygdala (exaggerated fear response) and a hypoactive medial prefrontal cortex (mPFC). Normally, the mPFC exerts inhibitory control over the amygdala to extinguish fear when a threat has passed; in PTSD, this top-down inhibition fails. Additionally, the hippocampus (responsible for contextualizing memories in time and space) is often reduced in volume and function. This causes traumatic memories to be experienced as fragmented, visceral flashbacks that feel like they are happening 'now' rather than 'then'. The hypothalamic-pituitary-adrenal (HPA) axis is also dysregulated, with chronically low baseline cortisol but hypersensitive glucocorticoid receptors, locking the body in a state of high sympathetic arousal.

Characteristic Clinical Presentation

• Intrusions (Flashbacks): Involuntary, distressing, and vivid re-experiencing of the trauma, often feeling as if it is happening in real-time.
• Avoidance: Active effort to avoid distressing memories, thoughts, people, places, or activities associated with the trauma.
• Negative Cognitions: Pervasive negative beliefs about oneself or the world ('I am broken', 'The world is completely dangerous'), detachment from others, inability to feel positive emotions.
• Hyperarousal: Hypervigilance, exaggerated startle response, irritable or aggressive behavior, and severe insomnia.

Physical Examination Signs

• Visible startle to sudden loud noises.
• Blunted affect or profound emotional numbing during interview.
• Tachycardia and diaphoresis when discussing trauma.

• Substance Use Disorder: Extremely high rate of alcohol/drug abuse as a method of self-medicating hyperarousal and nightmares.
• Suicidality: Significant risk of suicidal ideation and completed suicide.
• Cardiovascular Disease: Chronic high sympathetic tone increases long-term risk of hypertension and coronary artery disease.

Diagnostic Criteria & Guidelines

DSM-5 criteria require exposure to a traumatic event, followed by symptoms from 4 clusters lasting >1 month: 1) Intrusion (≥1 symptom), 2) Avoidance (≥1 symptom), 3) Negative alterations in cognitions and mood (≥2 symptoms), 4) Alterations in arousal and reactivity (≥2 symptoms). Symptoms must cause clinically significant distress or impairment.

Differential Diagnosis

• Acute Stress Disorder (duration < 1 month)
• Adjustment Disorder (stressor does not meet severe trauma criteria)
• Traumatic Brain Injury (TBI, often comorbid in veterans/accidents)
• Major Depressive Disorder
• Borderline Personality Disorder

Laboratory Tests & Biomarkers

• No diagnostic blood tests: Clinical diagnosis.
• Urine Toxicology: Crucial to screen for comorbid substance abuse.

Imaging Modalities & Findings

• fMRI (Research only):

• Acute Stress Disorder
  Symptoms occurring between 3 days and 1 month after the trauma.
• Acute PTSD
  Symptoms persisting for 1 to 3 months.
• Chronic PTSD
  Symptoms persisting for more than 3 months, often leading to deep functional decline and structural brain changes.
• Delayed-onset PTSD
  Full criteria are not met until at least 6 months after the event.

Second-Line & Adjunctive Therapy

If SSRIs fail, Mirtazapine or Tricyclic Antidepressants (Amitriptyline). For severe, treatment-resistant PTSD, off-label use of atypical antipsychotics (Quetiapine, Risperidone) as adjuncts. Prazosin (an alpha-1 blocker, 1-15 mg at bedtime) is frequently used specifically to suppress trauma-related nightmares, though recent large trials have shown mixed results.

Surgical & Procedural Management

None.

Recommended Lifestyle Changes

Patient Counseling & Advice

Validate the patient's experience; explain that their symptoms are a normal biological reaction to an abnormal event, not a sign of weakness. Emphasize that avoidance, while protective in the short term, fuels the disorder long-term. Prepare them that trauma-focused therapy is hard work and may temporarily increase anxiety before it gets better. Warn against the use of benzodiazepines, as they interfere with the fear extinction process required for therapy to work.

Follow-Up & Monitoring Schedule

Weekly or biweekly during active psychotherapy. Monitor heavily for signs of worsening depression, emergence of substance abuse, and suicidal ideation. Use the PTSD Checklist for DSM-5 (PCL-5) to track symptom severity over time.

Preventive Strategies

Providing rapid psychological first aid, ensuring safety, and fostering social support immediately after a trauma reduces PTSD risk. Routine debriefing (forcing people to recount the trauma immediately) is NOT recommended and may increase risk.

Highly variable. With evidence-based trauma-focused therapy, up to 50-60% of patients achieve remission. However, roughly one-third develop chronic, unremitting symptoms requiring lifelong management.